                         SEQUENCE LISTING

<110>  Vanderbilt University
 
<120>  HUMAN ANTIBODIES TO ZIKA VIRUS

<130>  VBLT.P0287WO

<140>  Unknown
<141>  2019-09-18

<150>  62/734,200
<151>  2018-09-20

<160>  21    

<170>  PatentIn version 3.5

<210>  1
<211>  366
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
gaggtgaagc tggtggagtc tgggagaggc ctagttcggc ctggggggtc cctgagactc       60

tcttgtgcag cctctggatt cacctttagc aactatgcca tgagctgggt ccgccagggt      120

ccagggatgg gactggagtg ggtctcaacg atcactgccg atagtgatag caaatattac      180

gtggactctg tgaagggccg gttcaccatc tccagagaca attccaagga cacattattt      240

ctacacatga ccagcctgag agccgaagac acggccgttt actactgtgc gaaagatcgc      300

ctctctcggg gggtcgggga gttatatgac tcgtggggcc agggaacgct ggtcatcgtc      360

tcctca                                                                 366


<210>  2
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
gacatacaga tgacccagtc tccttccacc ctgtctgcat ctgtaggaga cagagtcacc       60

atcacttgcc gggccagcca gagtattgat gtctggttgg cctggtatca gcagaagcca      120

gggaaagccc ctaaactcct gatgtataag acgtctactt tacaaactgg ggtcccatca      180

agattcagcg gcagtggatc tgggacagaa ttcactctca ccatcagcag cctgcagact      240

gatgattttg caacttatta ctgccaaaag tacgatagtt atccgtggac gttcggccca      300

gggaccaagg tggaaatcaa a                                                321


<210>  3
<211>  357
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  3
caggtgcaac tggtggagtc tgggggaggc gtggtccggc ctggggggtc cctcagactc       60

tcctgtgcag cgtctggatt caccttcaaa aactatggca tccactgggt ccgccaggct      120

ccaggcaagg ggccggagtg ggtggcattt gtacggtatg atggaaataa caagtactat      180

gcagactccg tgaagggccg attcaccatc tccagagaca atgccaagaa cacgctgtct      240

ctgcaaatga acagcctgag agttgaagac acggctgtct atttctgtgc gagggatcct      300

gaaactttcg gggggtttga ctactggggc cagggaaccc tggtcaccgt ctcctca         357


<210>  4
<211>  321
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
gaaacagtga tgacgcagtc tccagccacc ctgtctgtgt ctccagggga aagaggcacc       60

ctctcctgca gggccagtga gagtgttagc agcaacttgg cctggtacca gcagaaacct      120

ggcaaggctc cccggctcct catctatggt gcatccacca gggccactgg tatcccagac      180

aggttcagtg gcagtgggtc tgggacagag ttcactctca ccatcagcag cctgcagtct      240

gaagattttg cagtttatta ctgtcagcag tattattact cgcctcgaac gttcggccaa      300

gggaccaagg tggaagtcaa a                                                321


<210>  5
<211>  122
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  5

Glu Val Lys Leu Val Glu Ser Gly Arg Gly Leu Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr 
            20                  25                  30          


Ala Met Ser Trp Val Arg Gln Gly Pro Gly Met Gly Leu Glu Trp Val 
        35                  40                  45              


Ser Thr Ile Thr Ala Asp Ser Asp Ser Lys Tyr Tyr Val Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asp Thr Leu Phe 
65                  70                  75                  80  


Leu His Met Thr Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Lys Asp Arg Leu Ser Arg Gly Val Gly Glu Leu Tyr Asp Ser Trp 
            100                 105                 110         


Gly Gln Gly Thr Leu Val Ile Val Ser Ser 
        115                 120         


<210>  6
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  6

Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Asp Val Trp 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Met 
        35                  40                  45              


Tyr Lys Thr Ser Thr Leu Gln Thr Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Thr 
65                  70                  75                  80  


Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Lys Tyr Asp Ser Tyr Pro Trp 
                85                  90                  95      


Thr Phe Gly Pro Gly Thr Lys Val Glu Ile Lys 
            100                 105         


<210>  7
<211>  119
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  7

Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Arg Pro Gly Gly 
1               5                   10                  15      


Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Lys Asn Tyr 
            20                  25                  30          


Gly Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Pro Glu Trp Val 
        35                  40                  45              


Ala Phe Val Arg Tyr Asp Gly Asn Asn Lys Tyr Tyr Ala Asp Ser Val 
    50                  55                  60                  


Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ala Lys Asn Thr Leu Ser 
65                  70                  75                  80  


Leu Gln Met Asn Ser Leu Arg Val Glu Asp Thr Ala Val Tyr Phe Cys 
                85                  90                  95      


Ala Arg Asp Pro Glu Thr Phe Gly Gly Phe Asp Tyr Trp Gly Gln Gly 
            100                 105                 110         


Thr Leu Val Thr Val Ser Ser 
        115                 


<210>  8
<211>  107
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic polypeptide

<400>  8

Glu Thr Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly 
1               5                   10                  15      


Glu Arg Gly Thr Leu Ser Cys Arg Ala Ser Glu Ser Val Ser Ser Asn 
            20                  25                  30          


Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Arg Leu Leu Ile 
        35                  40                  45              


Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Asp Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser 
65                  70                  75                  80  


Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Tyr Tyr Ser Pro Arg 
                85                  90                  95      


Thr Phe Gly Gln Gly Thr Lys Val Glu Val Lys 
            100                 105         


<210>  9
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Gly Phe Thr Phe Ser Asn Tyr Ala 
1               5               


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Ile Thr Ala Asp Ser Asp Ser Lys 
1               5               


<210>  11
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Cys Ala Lys Asp Arg Leu Ser Arg Gly Val Gly Glu Leu Tyr Asp Ser 
1               5                   10                  15      


Trp 
    


<210>  12
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Gly Phe Thr Phe Lys Asn Tyr Gly 
1               5               


<210>  13
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Val Arg Tyr Asp Gly Asn Asn Lys 
1               5               


<210>  14
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Cys Ala Arg Asp Pro Glu Thr Phe Gly Gly Phe Asp Tyr Trp 
1               5                   10                  


<210>  15
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  15

Gln Ser Ile Asp Val Trp 
1               5       


<210>  16
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  16

Lys Thr Ser 
1           


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  17

Gln Lys Tyr Asp Ser Tyr Pro Trp Thr 
1               5                   


<210>  18
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  18

Glu Ser Val Ser Ser Asn 
1               5       


<210>  19
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  19

Gly Ala Ser 
1           


<210>  20
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  20

Gln Gln Tyr Tyr Tyr Ser Pro Arg Thr 
1               5                   


<210>  21
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic phosphorothioate-modified oligodeoxynucleotide


<220>
<221>  modified_base
<222>  (1)..(20)
<223>  phosphorothioate base

<400>  21
tcgtcgtttt tcggtcgttt t                                                 21


